Aspirin merits testing for prevention of cervical cancer in HIV-infected women
Wednesday, January 18, 2012 - 13:30
in Health & Medicine
Research conducted by NewYork-Presbyterian Hospital/Weill Cornell Medical Center global health investigators and cancer specialists in New York, Qatar and Haiti suggests that aspirin should be evaluated for its ability to prevent development of cervical cancer in HIV-infected women.